Evidence map›Paper›PMID 41463389›Full record

ArticleBiomolecules2025

Gold Nanoparticles-Enhanced Gene Transfer Driven by MHz-Frequency Nanosecond Pulsed Electric Fields.

Veronika Malyško-Ptašinskė, Eivina Radzevičiūtė-Valčiukė, Anna Szewczyk, Barbora Lekešytė, Paulina Malakauskaitė, Eglė Mickevičiūtė-Zinkuvienė, Augustinas Želvys, Natalija German, Julita Kulbacka, Vitalij Novickij

Abstract read
In one paragraph

Article in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Veronika Malyško-PtašinskėFaculty of Electronics, Vilnius Gediminas Technical University, LT-10223 Vilnius, Lithuania.ORCID 0000-0002-2438-5713
Eivina Radzevičiūtė-ValčiukėFaculty of Electronics, Vilnius Gediminas Technical University, LT-10223 Vilnius, Lithuania.ORCID 0000-0003-4588-7576
Anna SzewczykDepartment of Immunology and Bioelectrochemistry, State Research Institute Centre of Innovative Medicine, LT-08406 Vilnius, Lithuania.ORCID 0000-0003-0934-9180
Barbora LekešytėFaculty of Electronics, Vilnius Gediminas Technical University, LT-10223 Vilnius, Lithuania.ORCID 0000-0002-6339-8234
Paulina MalakauskaitėFaculty of Electronics, Vilnius Gediminas Technical University, LT-10223 Vilnius, Lithuania.ORCID 0009-0004-4265-5061
Eglė Mickevičiūtė-ZinkuvienėFaculty of Electronics, Vilnius Gediminas Technical University, LT-10223 Vilnius, Lithuania.ORCID 0009-0006-2656-2185
Augustinas ŽelvysFaculty of Electronics, Vilnius Gediminas Technical University, LT-10223 Vilnius, Lithuania.ORCID 0000-0002-1952-0431
Natalija GermanDepartment of Immunology and Bioelectrochemistry, State Research Institute Centre of Innovative Medicine, LT-08406 Vilnius, Lithuania.ORCID 0000-0002-7779-529X
Julita KulbackaDepartment of Immunology and Bioelectrochemistry, State Research Institute Centre of Innovative Medicine, LT-08406 Vilnius, Lithuania.ORCID 0000-0001-8272-5440
Vitalij NovickijFaculty of Electronics, Vilnius Gediminas Technical University, LT-10223 Vilnius, Lithuania.ORCID 0000-0001-6147-956X

Funding

Lietuvos Mokslo Taryba S-PD-24-5
6 · The paper itself

Abstract

Electroporation can be used as an effective non-viral gene delivery method, while the application of conductive nanoparticles (NPs) with pulsed electric fields (PEFs) may increase treatment efficacy due to local field amplification in close proximity to the cell plasma membrane. In this work, we have employed 100 ns and 300 ns pulses (9-17 kV/cm), which were delivered in bursts (n = 100) and predefined inter-pulse delays (100-900 ns), which enabled successful gene delivery (4.7 kbp; p-EGFP-N1) using pulses as short as 100 ns, which previously was considered impossible. As a model, a murine breast cancer cell line (4T1) was used. It was shown that sub-microsecond pulses (i.e., 300 ns) can be effective for gene delivery, whereas 100 ns pulses are several-fold inferior, yet still trigger successful gene transfer (>10% of cells being electrotransfected). In order to increase the efficacy of the treatment, we used gold nanoparticles (AuNPs; the diameter of 13 nm), which allowed us to achieve electrotransfection efficacy several-fold for both sub-microsecond and microsecond protocols (1.2 kV/cm × 100 µs × 8 pulses at 1 Hz). The results suggest high potential applicability of conductive nanoparticles in future translational or clinical research involving electroporation and gene transfer.

Indexed as

Gene Transfer TechniquesGoldMetal NanoparticlesAnimalsCell Line, TumorElectroporationFemaleGreen Fluorescent ProteinsMiceTransfectionGoldGreen Fluorescent Proteinselectroporationgene electrotransferGFPgold nanoparticleshigh-frequencyin vitronanosecond

Identifiers

PMID41463389
PMCPMC12730680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.